Copper T-Shaped Cervical Device for HPV Protection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack an effective solution for reducing the incidence and prevalence of human papillomavirus (HPV) types 16 and 18, which are major contributors to uterine cervical cancer, and for enhancing local immunity in women, while also serving as a contraceptive device.

Innovation Solution

A uterine cervical device comprising copper, designed to be placed between the cervix and uterus, with a T-shaped frame and copper filaments, modifies the cervical microbiota, reduces inflammatory responses, and increases leukocyte levels, thereby enhancing local immunity and preventing HPV-related cancers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional contraceptive methods are used, then contraception is provided, but protection against HPV and cervical cancer is not achieved

Engineering Contradiction:
Improveprotection against HPV and cervical cancerVSAvoidmulti-functionality of contraceptive device
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The intrauterine device is designed to perform multiple functions simultaneously: contraception through copper ion release, HPV prevention through microbiome modification, and immune system stimulation through leukocyte attraction. This multi-functionality resolves the contradiction by integrating several protective mechanisms into a single device that addresses both contraceptive needs and cervical cancer prevention.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The device combines copper filaments with a T-shaped frame structure, creating a composite material system that releases copper ions while maintaining structural integrity. This composite approach enables the device to achieve both contraceptive efficacy and antiviral protection through the synergistic effects of the materials used.

Inventive Principle:
Principle #40Composite materials

2Reliability

If copper area is increased to enhance HPV protection, then immune response is improved, but device complexity increases

Engineering Contradiction:
Improveimmune response and HPV protectionVSAvoiddevice structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The copper is divided into multiple filaments arranged in a specific pattern on the T-shaped frame, rather than using a single large copper component. This segmentation allows for optimized copper distribution that enhances immune response while maintaining manageable device complexity through modular construction.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The device specifies a copper area between 380-524 mm² with optimal ranges identified through research. By optimizing this critical parameter, the device achieves maximum immune stimulation and HPV protection efficacy without unnecessarily increasing complexity, as the copper area is carefully controlled within specific boundaries.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device effectively decreases the viral load of HPV, reduces the progression of precancerous lesions, and enhances local immunity, providing protection against HPV and other sexually transmitted infections, thus preventing the development of uterine cervical cancer.

Implementation Method 1

A uterine cervical device comprising copper, designed to be placed between the cervix and uterus

Methodology Applied
Scientific EffectCopper ion release:

Implementation Method 2

modifies the cervical microbiota, reduces inflammatory responses

Methodology Applied
Scientific EffectAntimicrobial effect:

Implementation Method 3

reduces inflammatory responses, and increases leukocyte levels

Methodology Applied
Scientific EffectAnti-inflammatory effect:

Implementation Method 4

increases leukocyte levels, thereby enhancing local immunity

Methodology Applied
Scientific EffectLeukocyte recruitment:

Implementation Method 5

decreases the viral load of HPV, reduces the progression of precancerous lesions

Methodology Applied
Scientific EffectViral clearance:

Data Source

PatentUS11857675B2Method for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections
Publication Date: 2024.01.02 ESPARZA BARBARA SANDERS
  • US11857675B2 patent drawing

AI summary

Methods comprising the insertion of a uterine cervical device into the lower part of the uterine cavity and endocervix for decreasing the incidence of the human papillomavirus in women, mainly types 16 and 18, thus preventing the development of uterine cervical cancer; for modifying the cervical microbiota; for increasing leukocytes and protecting against sexually transmitted infections in women.